0168K0·Stock-Sector-Healthcare
TIGER TECHNOLOGY TRANSFER BIO ACTIVE
Introduction
The TIGER TECHNOLOGY TRANSFER BIO ACTIVE ETF aims to outperform the KRX Technology Transfer Bio Index by actively adjusting weightings and selectively including non-benchmark asset in its portfolio
Investment Points
An ETF investing in Korean biotechnology companies that possess a proven track record of technology out-licensing.
Benchmark Index
KRX Technology Transfer Bio Index
Benchmark Index Description
An index comprising up to 15 Korean-listed biotechnology stocks with the highest out-licensing deal values.
Issuer
Mirae Asset Global Investments Co.,Ltd.
Brand
TIGER
Total Fee
0.5
Listing Date
2026-03-17
International Securities Code
KR70168K0008
Market Information
Market Capitalization
149,744,700,000KRW
Transaction Amount
12,653,062,957KRW
Trading Volume
1,284,613
Shares Outstanding
15,390,000
NAV
9,729
52-Week High
11,205KRW
52-Week Low
9,005KRW